Cargando…

Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin

BACKGROUND: Conjugation of anti-neoplastic agents with human proteins is a strategy to diminish the toxic side effects of anthracycline antibiotics. We have developed a novel doxorubicin-transferrin (DOX-TRF) conjugate aimed to direct anticancer drugs against therapeutic targets that display altered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szwed, Marzena, Kania, Katarzyna D., Jozwiak, Zofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255090/ https://www.ncbi.nlm.nih.gov/pubmed/25410120 http://dx.doi.org/10.1007/s13402-014-0205-5

Ejemplares similares

Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation
por: Szwed, Marzena, et al.
Publicado: (2015)

Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells
por: Jedrzejczyk, Monika, et al.
Publicado: (2020)

Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
por: Łubgan, Dorota, et al.
Publicado: (2008)

Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells
por: Wigner, Paulina, et al.
Publicado: (2021)

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
por: Soe, Zar Chi, et al.
Publicado: (2019)

Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer
por: GUO, YAJUN, et al.
Publicado: (2015)

Bone-Targeted Acid-Sensitive Doxorubicin Conjugate Micelles as Potential Osteosarcoma Therapeutics
por: Low, Stewart A., et al.
Publicado: (2014)

Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
por: Wang, He-Wen, et al.
Publicado: (2020)

Deposition of Doxorubicin in Rats following Administration of Three Newly Synthesized Doxorubicin Conjugates
por: Huan, Menglei, et al.
Publicado: (2013)

Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin
por: Han, Yiqun, et al.
Publicado: (2014)

Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2019)

Photo- and Acid-Degradable Polyacylhydrazone–Doxorubicin Conjugates
por: Psarrou, Maria, et al.
Publicado: (2021)

Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems
por: Bognanni, Noemi, et al.
Publicado: (2023)

Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.
por: Asakura, T., et al.
Publicado: (1997)

Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells
por: Czepas, Jan, et al.
Publicado: (2020)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Mitofusin-2 mediates doxorubicin sensitivity and acute resistance in Jurkat leukemia cells
por: Decker, Carl W., et al.
Publicado: (2020)

Development of Doxorubicin-Loaded Magnetic Silica–Pluronic F-127 Nanocarriers Conjugated with Transferrin for Treating Glioblastoma across the Blood–Brain Barrier Using an in Vitro Model
por: Heggannavar, Geetha B., et al.
Publicado: (2018)

Immunoproteasome Inhibitor–Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon Irradiation
por: Maurits, Elmer, et al.
Publicado: (2020)

A dual-responsive doxorubicin–indoximod conjugate for programmed chemoimmunotherapy
por: Yang, Zhaoxuan, et al.
Publicado: (2022)

Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo
por: Gan, Donghui, et al.
Publicado: (2021)

Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
por: Khaleel, Sahar A., et al.
Publicado: (2016)

Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
por: Kuruvilla, Sibu P., et al.
Publicado: (2017)

[(WR)(8)WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin
por: Zoghebi, Khalid, et al.
Publicado: (2022)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity
por: Chappell, William H., et al.
Publicado: (2012)

Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
por: Kowalska, Karolina, et al.
Publicado: (2020)

The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
por: Patel, Krupa J, et al.
Publicado: (2009)

Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
por: Kim, Tae Hwan, et al.
Publicado: (2018)

Potential Therapeutic Treatments for Doxorubicin-Induced Cardiomyopathy
por: Kabir, Shadman, et al.
Publicado: (2022)

Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate
por: Asakura, T, et al.
Publicado: (1999)

Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer
por: Salaam, Amanee D, et al.
Publicado: (2014)

Cross-beta nanostructures based on dinaphthylalanine Gd-conjugates loaded with doxorubicin
por: Diaferia, Carlo, et al.
Publicado: (2017)

Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
por: Butowska, Kamila, et al.
Publicado: (2023)

Protein binding of 4-hydroxybenzoic acid and 4-hydroxy-3-methoxybenzoic acid to human serum albumin and their anti-proliferation on doxorubicin-sensitive and doxorubicin-resistant leukemia cells
por: Myint, Ohnmar, et al.
Publicado: (2021)

Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
por: Li, Rifei, et al.
Publicado: (2022)

Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression
por: Lu, Yong-lin, et al.
Publicado: (2019)

Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma—In Vitro Studies
por: Małek, Anna, et al.
Publicado: (2021)

Improved in vivo Antitumor Efficacy and Reduced Systemic Toxicity of Carboxymethylpullulan‐peptide‐doxorubicin Conjugates
por: Nogusa, Hideo, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_tu5f3lvhe6017svmrdp8f7rem9